News
SDMHF
229.00
NaN%
--
Sartorius Stedim Biotech (0RG8) Gets a Buy from Barclays
TipRanks · 3d ago
Sartorius Stedim Biotech Updates Share Capital and Voting Rights Structure
TipRanks · 09/03 14:35
Sartorius Stedim upgraded to Buy from Neutral at UBS
TipRanks · 08/20 08:45
RBC Capital Remains a Buy on Sartorius Stedim Biotech (0RG8)
TipRanks · 08/12 05:15
Sartorius Stedim Biotech Updates Market on Share Capital and Voting Rights
TipRanks · 08/04 08:32
Sartorius Stedim Biotech (0RG8) Gets a Buy from Bernstein
TipRanks · 07/28 13:46
Sartorius Stedim Biotech (0RG8) Receives a Buy from J.P. Morgan
TipRanks · 07/24 11:05
RBC Capital Keeps Their Buy Rating on Sartorius Stedim Biotech (0RG8)
TipRanks · 07/23 12:57
Sartorius Stedim Biotech Delivers H1 Growth and Confirms 2026 Outlook
TipRanks · 07/23 05:43
UBS Remains a Hold on Sartorius Stedim Biotech (0RG8)
TipRanks · 07/13 12:05
J.P. Morgan Sticks to Its Buy Rating for Sartorius Stedim Biotech (0RG8)
TipRanks · 06/22 11:25
Sartorius Stedim price target lowered to EUR 230 from EUR 233 at HSBC
TipRanks · 06/03 09:30
Sartorius Stedim Biotech (0RG8) Gets a Buy from RBC Capital
TipRanks · 05/06 05:36
Invesco International Growth Fund Q1 2026 Portfolio Review
Seeking Alpha · 05/01 12:53
Sartorius Stedim Biotech (0RG8) Gets a Buy from Barclays
TipRanks · 04/23 14:36
Sartorius Stedim Biotech S.A. GAAP EPS of €0.91, revenue of €761.5M
Seeking Alpha · 04/23 12:06
Sartorius Stedim Biotech (0RG8) Receives a Buy from RBC Capital
TipRanks · 04/23 10:36
J.P. Morgan Sticks to Its Buy Rating for Sartorius Stedim Biotech (0RG8)
TipRanks · 04/23 10:36
Sartorius Stedim Biotech (0RG8) Gets a Buy from Goldman Sachs
TipRanks · 04/23 07:05
Sartorius Stedim Biotech Q1 Profit Rises On Revenue Growth; Confirms FY26 Outlook
NASDAQ · 04/23 05:29
More
Webull provides a variety of real-time SDMHF stock news. You can receive the latest news about Sartorius Stedim through multiple platforms. This information may help you make smarter investment decisions.
About SDMHF
Sartorius Stedim Biotech SA is a France-based international provider of laboratory and process technologies and equipment. The Company covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The Company operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.